H.C. Wainwright Reiterates Its ‘Buy’ Rating on Anavex Life Sciences Corp. (AVXL) with a $42 Price Target
On September 11, 2025, H.C. Wainwright reiterated its ‘Buy’ rating on Anavex Life Sciences Corp. (NASDAQ:AVXL) with a $42 price target.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Two Sigma Advisors John Overdeck And David Siegel | 823,400 | $7,591,748 | +63% | 0.02% |
2. | 390,000 | $3,595,800 | 0.01% | ||
3. | Citadel Investment Group Ken Griffin | 322,205 | $2,970,730 | +67876% | 0% |
4. | 294,400 | $2,714,368 | -8% | 0% | |
5. | Balyasny Asset Management Dmitry Balyasny | 245,624 | $2,264,653 | +44% | 0% |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$3.64 | 2,835 | $10,319.40 | 5,000 | 2024-06-14 | Filing | |
$4.52 | 5,000 | $22,600.00 | 5,000 | 2024-05-15 | Filing | |
$10.93 | 1,000 | $10,930.00 | 2,165 | 2021-05-17 | Filing | |
$12.97 | 165 | $2,140.05 | 1,165 | 2021-02-19 | Filing | |
$12.62 | 1,000 | $12,620.00 | 1,000 | 2021-02-19 | Filing |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$5.11 | 73,380 | $374,971.80 | 1,250,210 | 2024-03-28 | Filing | |
$7.98 | 268,000 | $2,139,310.00 | 1,018,210 | 2023-06-28 | Filing | |
$9.06 | 50,000 | $453,000.00 | 1,306,458 | 2022-05-25 | Filing | |
$26.00 | 51,620 | $1,342,120.00 | 1,018,210 | 2021-06-29 | Filing | |
$26.53 | 166,696 | $4,422,444.88 | 22,963 | 2021-06-29 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 135,948 | $1,209,937 | 0.78% | |
2. | 40,478 | $403,161 | 0.03% | |
3. | 15,635 | $139,152 | 0% | |
4. | 15,000 | $133,500 | 0.01% | |
5. | 10,250 | $91,225 | 0.02% |